In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes
- 25 October 2001
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 16 (7) , 541-544
Abstract
The metabolism of mirtazapine enantiomers was investigated in vitro using human lymphoblast microsomes transfected with human cDNA to overexpress either CYP1A2, CYP2C9, CYP2C19, CYP2D6 or CYP3A4 and assayed for mirtazapine enantiomers using a validated chiral method of high‐performance liquid chromatography. (+)‐Mirtazapine was extensively metabolised by CYP2D6 (Km = 9.3 ± 3.3 μmol/l, Vmax = 40.9 ± 7.9 μmol/h/mg, intrinsic clearance = 4.41 l/h/mg). CYP1A2 and CYP3A4 showed low metabolic activity towards (+)‐mirtazapine and (−)‐mirtazapine respectively. Neither CYP2C9 nor CYP2C19 appeared to be involved in the metabolism of the enantiomers of mirtazapine. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 9 references indexed in Scilit:
- Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Neurochemical effects of the enantiomers of mirtazapine in normal ratsEuropean Journal of Pharmacology, 1998
- A Comparison of the Physicochemical and Biological Properties of Mirtazapine and MianserinJournal of Pharmacy and Pharmacology, 1997
- Antidepressant and Double Antidepressant Treatment for the Affective Disorder of EpilepsyThe Journal of Clinical Psychiatry, 1997
- [22] CYP2D6 multiallelism1996
- The Selective α2-Adrenoceptor Antagonist Mirtazapine (Org 3770) Enhances Noradrenergic and 5-HT1A-Mediated Serotonergic NeurotransmissionCNS Drugs, 1995
- Human cell lines, derived from AHH-1 TK+/− human lymphoblasts, genetically engineered for expression of cytochromes P450Toxicology, 1993
- EZ-FIT: A practical curve-fitting microcomputer program for the analysis of enzyme kinetic data on IBM-PC compatible computersAnalytical Biochemistry, 1988
- Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomersNeuropharmacology, 1988